To study the effect of nebulized dexmedetomidine in different doses during bronchoscopic procedure
Not Applicable
- Conditions
- Health Condition 1: J989- Respiratory disorder, unspecified
- Registration Number
- CTRI/2019/10/021629
- Lead Sponsor
- AIIMS Patna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA I/II
2. Scheduled for elective bronchoscopy procedure (Diagnostic & therapeutic)
Exclusion Criteria
1.Unconscious and uncooperative patients
2.Intubated patient on ventilator, patient need general anaesthesia,
3.Patient on oxygen
4.Allergic to LA, dexmedetomidine
5.Asthmatics
6.Epileptics
7.Coagulation abnormalities
8.Haemodynamic instability, bradyarrhythmias
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough severity scoreTimepoint: At 0 min (base line), 5 min, 10 min, 15 min, 20 min (during insertion of bronchoscope), 25min, 30 min , 45 min and at 60 min.
- Secondary Outcome Measures
Name Time Method Patient comfortTimepoint: At 0 min (base line), 5 min, 10 min, 15 min, 20 min (during insertion of bronchoscope), 25min, 30 min , 45 min and at 60 min.